Investment analysts at StockNews.com began coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the stock. Aspira ...

AUSTIN, TX / ACCESSWIRE / January 10, 2025 / Aspira Women's Health Inc. ('Aspira' or the 'Company') (Nasdaq:AWH), a bio-analytical based women's health company focused on the development of ...

Equities researchers at StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Get Free Report) in ...

Bifikafusp alfa + onfekafusp alfa is under clinical development by Philogen and currently in Phase II for Kaposi Sarcoma.